论文部分内容阅读
目的:观察保尔佳治疗晚期恶性肿瘤患者的效果,对生存质量的影响。方法:晚期恶性肿瘤79例,随机分组,保尔佳组42例,对照组37例。结果:用药2周后,保尔佳组食欲增加显著,P<0.01;止痛观察,两组无显著差异,P>0.05,但保尔佳与止痛药物有协同止痛作用;用药4周后,体重变化、Karnofspy评分两组有显著差异,P值分别小于0.01和0.05。结论:保尔佳能显著改善晚期恶性肿瘤患者的生存质量。
OBJECTIVE: To observe the effect of Pulcan in the treatment of patients with advanced malignant tumors and their influence on the quality of life. Methods: Seventy-nine cases of advanced malignant tumors were randomly divided into two groups: 42 in the Baoerjia group and 37 in the control group. RESULTS: After 2 weeks of treatment, the appetite increased significantly in Pauerjia group (P<0.01). There was no significant difference between the two groups in pain relief (P>0.05), but Palladium and analgesic drugs had a synergistic analgesic effect; after 4 weeks of treatment, body weight Changes in Karnofspy scores were significantly different between the two groups, with P values less than 0.01 and 0.05, respectively. Conclusion: Paul Canon significantly improved the quality of life of patients with advanced malignant tumors.